| Mechanisms and factors that influence high frequency retroviral recombination K Delviks-Frankenberry, A Galli, O Nikolaitchik, H Mens, VK Pathak, ... Viruses 3 (9), 1650-1680, 2011 | 106 | 2011 |
| Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus A Galli, J Bukh Trends in microbiology 22 (6), 354-364, 2014 | 89 | 2014 |
| Cytoplasmic HIV-1 RNA is mainly transported by diffusion in the presence or absence of Gag protein J Chen, D Grunwald, L Sardo, A Galli, S Plisov, OA Nikolaitchik, D Chen, ... Proceedings of the National Academy of Sciences 111 (48), E5205-E5213, 2014 | 82 | 2014 |
| Overcoming culture restriction for SARS-CoV-2 in human cells facilitates the screening of compounds inhibiting viral replication S Ramirez, C Fernandez-Antunez, A Galli, A Underwood, LV Pham, ... Antimicrobial Agents and Chemotherapy 65 (7), 10.1128/aac. 00097-21, 2021 | 70 | 2021 |
| Changing patterns in HIV‐1 non‐B clade prevalence and diversity in Italy over three decades* A Lai, C Riva, A Marconi, M Balestrieri, F Razzolini, G Meini, I Vicenti, ... HIV medicine 11 (9), 593-602, 2010 | 65 | 2010 |
| Productive homologous and non-homologous recombination of hepatitis C virus in cell culture TKH Scheel, A Galli, YP Li, LS Mikkelsen, JM Gottwein, J Bukh PLoS pathogens 9 (3), e1003228, 2013 | 58 | 2013 |
| Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations J Prentoe, R Velázquez-Moctezuma, EH Augestad, A Galli, R Wang, ... Proceedings of the National Academy of Sciences 116 (20), 10039-10047, 2019 | 50 | 2019 |
| Patterns of Human Immunodeficiency Virus Type 1 Recombination Ex Vivo Provide Evidence for Coadaptation of Distant Sites, Resulting in Purifying Selection for … A Galli, M Kearney, OA Nikolaitchik, S Yu, MPS Chin, F Maldarelli, ... Journal of virology 84 (15), 7651-7661, 2010 | 50 | 2010 |
| Interactions between HIV-1 Gag and viral RNA genome enhance virion assembly KA Dilley, OA Nikolaitchik, A Galli, RC Burdick, L Levine, K Li, A Rein, ... Journal of virology 91 (16), 10.1128/jvi. 02319-16, 2017 | 44 | 2017 |
| Antiviral effect of ribavirin against HCV associated with increased frequency of G-to-A and C-to-U transitions in infectious cell culture model A Galli, H Mens, JM Gottwein, J Gerstoft, J Bukh Scientific reports 8 (1), 4619, 2018 | 40 | 2018 |
| Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro KA Gammeltoft, Y Zhou, CR Duarte Hernandez, A Galli, A Offersgaard, ... Antimicrobial Agents and Chemotherapy 65 (9), 10.1128/aac. 02680-20, 2021 | 39 | 2021 |
| Mechanisms of Human Immunodeficiency Virus Type 2 RNA Packaging: Efficient trans Packaging and Selection of RNA Copackaging Partners N Ni, OA Nikolaitchik, KA Dilley, J Chen, A Galli, W Fu, V Prasad, RG Ptak, ... Journal of virology 85 (15), 7603-7612, 2011 | 37 | 2011 |
| Determining the frequency and mechanisms of HIV-1 and HIV-2 RNA copackaging by single-virion analysis KA Dilley, N Ni, OA Nikolaitchik, J Chen, A Galli, WS Hu Journal of virology 85 (20), 10499-10508, 2011 | 35 | 2011 |
| Analysis of hepatitis C virus core/NS5A protein co-localization using novel cell culture systems expressing core–NS2 and NS5A of genotypes 1–7 A Galli, TKH Scheel, JC Prentoe, LS Mikkelsen, JM Gottwein, J Bukh Journal of General Virology 94 (10), 2221-2235, 2013 | 32 | 2013 |
| Hepatitis C virus escape studies of human antibody AR3A reveal a high barrier to resistance and novel insights on viral antibody evasion mechanisms R Velázquez-Moctezuma, A Galli, M Law, J Bukh, J Prentoe Journal of Virology 93 (4), 10.1128/jvi. 01909-18, 2019 | 27 | 2019 |
| Multiple barriers to recombination between divergent HIV-1 variants revealed by a dual-marker recombination assay OA Nikolaitchik, A Galli, MD Moore, VK Pathak, WS Hu Journal of molecular biology 407 (4), 521-531, 2011 | 23 | 2011 |
| Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters S Corvasce, M Violin, L Romano, F Razzolini, I Vicenti, A Galli, P Duca, ... Antiviral therapy 11 (3), 329-334, 2006 | 23 | 2006 |
| Delineation of the Preferences and Requirements of the Human Immunodeficiency Virus Type 1 Dimerization Initiation Signal by Using an In Vivo Cell-Based … ITM Hussein, N Ni, A Galli, J Chen, MD Moore, WS Hu Journal of virology 84 (13), 6866-6875, 2010 | 22 | 2010 |
| Efficacy of ion-channel inhibitors amantadine, memantine and rimantadine for the treatment of SARS-CoV-2 in vitro Y Zhou, KA Gammeltoft, A Galli, A Offersgaard, U Fahnøe, S Ramirez, ... Viruses 13 (10), 2082, 2021 | 19 | 2021 |
| Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique … A Galli, A Lai, S Corvasce, F Saladini, C Riva, L Deho, I Caramma, ... Journal of general virology 89 (12), 3119-3125, 2008 | 17 | 2008 |
Jens BukhProfessor at University of CopenhagenVerified email at sund.ku.dk
